Elixxer Stock Today
| ELXR Stock | CAD 1.15 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Elixxer is selling for under 1.15 as of the 24th of November 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.15. Elixxer has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Elixxer are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of December 2022 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. ELIXXER is traded on Commodity Exchange in Exotistan. The company has 11.34 M outstanding shares of which 238 shares are currently shorted by private and institutional investors with about 0.67 days to cover all short positions. More on Elixxer
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Elixxer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Elixxer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Elixxer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Mazen Haddad | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
Elixxer's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Elixxer's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsElixxer can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Elixxer's financial leverage. It provides some insight into what part of Elixxer's total assets is financed by creditors.
| |||||
Elixxer (ELXR) is traded on TSX Venture Exchange in Canada and employs 17 people. Elixxer is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elixxer's market, we take the total number of its shares issued and multiply it by Elixxer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elixxer operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.34 M outstanding shares of which 238 shares are currently shorted by private and institutional investors with about 0.67 days to cover all short positions.
Elixxer has accumulated about 969.92 K in cash with (2.35 M) of positive cash flow from operations.
Check Elixxer Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Elixxer is C$13.05 Million. 30% of Elixxer outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Elixxer Ownership Details
Elixxer Stock Against Markets
| ELXR | 0.00 |
|
| Competition | Refresh |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elixxer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Elixxer Corporate Management
Elected by the shareholders, the Elixxer's board of directors comprises two types of representatives: Elixxer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixxer. The board's role is to monitor Elixxer's management team and ensure that shareholders' interests are well served. Elixxer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixxer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Lenigas | Co-Chairman of the Board | Profile | |
| Anthony Samaha | Director | Profile | |
| Jeanne Wyk | Vice Communications | Profile | |
| Michael Kozub | Corporate Secretary | Profile | |
| Jeff Cheah | Director | Profile | |
| John McMullen | President | Profile |
Additional Tools for Elixxer Stock Analysis
When running Elixxer's price analysis, check to measure Elixxer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixxer is operating at the current time. Most of Elixxer's value examination focuses on studying past and present price action to predict the probability of Elixxer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixxer's price. Additionally, you may evaluate how the addition of Elixxer to your portfolios can decrease your overall portfolio volatility.